Keyword
Quick search:
Content Search
Result Content Research
Result Content Research
1 TherapeuticsMD Inc. stock outperforms market on strong trading day
2 TherapeuticsMD Announces Appointment of Mark Glickman as Chief Business Officer
3 Where Do Hedge Funds Stand On TherapeuticsMD Inc (TXMD)?
4 TherapeuticsMD Inc. stock underperforms Friday when compared to competitors
5 TherapeuticsMD Inc (NASDAQ:TXMD) Stock Jumps 7% in a Week: Here is Why
6 TherapeuticsMD Inc. stock rises Friday, outperforms market
7 TherapeuticsMD Inc. stock underperforms Wednesday when compared to competitors
8 TherapeuticsMD Inc. stock underperforms Thursday when compared to competitors
9 TherapeuticsMD Inc. stock falls Friday, underperforms market
10 TherapeuticsMD Inc. stock rises Tuesday, outperforms market
11 Do Insiders Own Lots Of Shares In TherapeuticsMD, Inc. (NASDAQ:TXMD)?
12 TherapeuticsMD Inc. stock outperforms competitors on strong trading day
13 TherapeuticsMD : Announces Appointment of Mark Glickman as Chief Business Officer
14 How Have Insiders Been Trading TherapeuticsMD Inc. (TXMD) Stock?
15 Is Buying Stock In TherapeuticsMD Inc. (TXMD) A Good Move Today?
16 TherapeuticsMD (TXMD) falls 0.44% for October 14
17 TherapeuticsMD (TXMD) falls 2.71% for September 29
18 TherapeuticsMD (TXMD) gains 4.60% in Light Trading on October 12
19 Narrower IRS reporting requirements don't move needle with banks
20 TherapeuticsMD (TXMD) gains 3.94% to Close at $0.74 on October 5
21 When Will TherapeuticsMD, Inc. (NASDAQ:TXMD) Turn A Profit?
22 TherapeuticsMD, Inc. (TXMD) Q1 2021 Earnings Call Transcript
23 TherapeuticsMD Announces Issuance of a J-Code for ANNOVERA® to Be Utilized in the Public Health Sector
24 TherapeuticsMD Announces Appointment of Hugh O’Dowd as President
25 Is TherapeuticsMD (TXMD) Stock a Buy For 2021?
26 TherapeuticsMD Announces Second Quarter 2021 Financial Results
27 TherapeuticsMD, Inc. (TXMD) Q4 2020 Earnings Call Transcript
28 TherapeuticsMD Announces Pricing of $110 Million Public Offering of Common Stock
29 TherapeuticsMD to Report Second Quarter 2021 Results on August 4, 2021
30 TherapeuticsMD Announces Fourth Quarter and Full-Year 2020 Financial Results
31 TherapeuticsMD Inc. stock falls Monday, underperforms market
32 Do Institutions Own TherapeuticsMD, Inc. (NASDAQ:TXMD) Shares?
33 TherapeuticsMD Announces Closing of its Underwritten Public Offering of Common Stock
34 Where Will TherapeuticsMD Inc (TXMD) Stock Go Next After It Is Down 5.00% in a Week?
35 Trade Alert: The Independent Director Of TherapeuticsMD, Inc. (NASDAQ:TXMD), Cooper Collins, Has Just Spent US$725k Buying 422% More Shares
36 Have Insiders Been Buying TherapeuticsMD, Inc. (NASDAQ:TXMD) Shares?
37 The Sun Sentinel Names TherapeuticsMD, Inc. a Winner of the South Florida Top Workplaces 2021 Award
38 TherapeuticsMD Inc. stock underperforms Tuesday when compared to competitors
39 TherapeuticsMD Announces Participation in Upcoming Investor Conferences
40 TherapeuticsMD, Inc. (NASDAQ:TXMD) Analysts Are More Bearish Than They Used To Be
41 What Kind Of Shareholders Hold The Majority In TherapeuticsMD, Inc.'s (NASDAQ:TXMD) Shares?
42 TherapeuticsMD Inc. stock outperforms competitors despite losses on the day
43 TherapeuticsMD Inc. stock rises Wednesday, outperforms market
44 TherapeuticsMD Inc (TXMD) Stock: Do Analysts Think You Should Hold?
45 TXMD: Should TherapeuticsMD Be in Your Portfolio?
46 TherapeuticsMD Announces Submission of Low Dose BIJUVA® 0.5 mg/100 mg Supplemental New Drug Application to FDA
47 Does TherapeuticsMD Inc (TXMD) Have What it Takes to be in Your Portfolio Thursday?
48 TherapeuticsMD Inc. stock falls Thursday, underperforms market
49 TherapeuticsMD Inc. stock rises Tuesday, still underperforms market
50 If You Invested $1000 In TherapeuticsMD Stock One Year Ago, Here's How Much You'd Have Now
51 TherapeuticsMD Inc. stock rises Thursday, outperforms market
52 TherapeuticsMD Announces First Quarter 2021 Financial Results
53 TherapeuticsMD Inc. stock rises Friday, still underperforms market
54 TherapeuticsMD® Announces Third Quarter 2020 Financial Results
55 TherapeuticsMD Inc. stock falls Wednesday, still outperforms market
56 Should You Sell TherapeuticsMD Inc (TXMD) in Drug Manufacturers
57 TherapeuticsMD Inc. stock remains steady Wednesday, underperforms market
58 TherapeuticsMD, Inc. (TXMD) Q3 2020 Earnings Call Transcript
59 TherapeuticsMD: Great Product, But We Are Underwhelmed By Execution
60 Should You Buy TherapeuticsMD Inc (TXMD) Stock Tuesday?
61 TherapeuticsMD Announces Participation in the Stifel 2020 Virtual Healthcare Conference
62 Therapeutics MD Is Urging Women to 'Take Pause' During Menopause Awareness Month
63 Bio-identical Hormones Market – Factors such as increasing geriatric population and females in the menopausal age group are expected to boost the growth of the market
64 5 Penny Stocks Insiders Are Buying
65 TherapeuticsMD's (TXMD) CEO Rob Finizio on Q2 2021 Results
66 TherapeuticsMD Inc (TXMD) Up 5.41% in Premarket Trading
67 TherapeuticsMD: Annovera May Save The Day
68 TherapeuticsMD (NASDAQ:TXMD) Stock In Downtrend: How to Trade Now?
69 How Much Did TherapeuticsMD's(NASDAQ:TXMD) Shareholders Earn From Share Price Movements Over The Last Five Years?
70 Comedian Whitney Cummings Partners with TherapeuticsMD to Launch “Just Say Vagina”
71 TXMD Stock Price Increases Over 35% Pre-Market: Why It Happened
72 POPSUGAR Launches New Women's Health Destination, “Full Disclosure,” in Collaboration With TherapeuticsMD
73 Catalyst Pharma, TherapeuticsMD May Be Next WallStreetBets Targets
74 TherapeuticsMD stock slides 6% after SEC charges company with breaking disclosure rules
75 Therapeuticsmd Inc (TXMD) gains 6.96% for May 20
76 TherapeuticsMD: Q3 Report Reveals Strong Rebound And Bolsters Commercial Outlook
77 TherapeuticsMD Provides COVID-19-Related Business Update
78 Hedge Funds Are Dumping TherapeuticsMD Inc (TXMD)
79 TherapeuticsMD Announces Patent Updates for ANNOVERA®
80 TherapeuticsMD Announces Submission of New Drug Application Prior Approval Efficacy Supplement to the U.S. Food and Drug Administration for Lower Dose of BIJUVA®
81 Is TherapeuticsMD Stock a Buy?
82 Knight and TherapeuticsMD Announce Health Canada Approval of BIJUVA®
83 Is TXMD A Good Stock To Buy Now?
84 TXMD.A
85 Did Hedge Funds Drop The Ball On TherapeuticsMD Inc (TXMD) ?
86 Pre-market Movers In Healthcare Sector: OCGN, TXMD, PPBT, KMPH, THTX…
87 10 Best Pharmaceutical Stocks to Buy According to Billionaire Joseph Edelman
88 22 Stocks Moving in Friday's Pre-Market Session
89 TherapeuticsMD's Hormone Therapy Approved in U.K. and Belgium
90 TherapeuticsMD, An Innovative Women's Healthcare Company, And PlushCare, A Virtual Health Platform, Announce Enhanced Access To Women's Health Products
91 If You Invested $1000 In Nike Stock One Year Ago, Here's How Much You'd Have Now
92 BRIEF-TherapeuticsMD Provides Business Update On Covid-19 Pandemic
93 TherapeuticsMD: Remaining Bullish On This Reopening Play In The Biotech Sector
94 TherapeuticsMD Closes $300 Million Non-Dilutive Term Loan Financing Facility with TPG Sixth Street Partners
95 Analyst Rating: Will TherapeuticsMD Inc (TXMD) Stock Outperform the Market?
96 What Wall Street expects from TherapeuticsMD's earnings
97 Is TherapeuticsMD (TXMD) Stock a Good Buy in 2021?
98 The Daily Biotech Pulse: Lilly, Regeneron Ink COVID-19 Drug Deal With US, Regulatory Setback For Calliditas, Theravance To Cut 75% Jobs, 4 IPOs
99 How is TherapeuticsMD Inc (TXMD) Stock's Recent Performance Affecting Investor's Feelings?
100 TherapeuticsMD, Inc. Acquires VitaMedMD, LLC